PCSK9 Inhibition for Therapeutic Decision-Making: Assessing the Value.
Citation: Journal of the American College of Cardiology. 75(18):2309-2311, 2020 05 12.PMID: 32381161Institution: MedStar Heart & Vascular InstituteForm of publication: Journal ArticleMedline article type(s): EditorialSubject headings: *Acute Coronary Syndrome | *Proprotein Convertase 9 | Antibodies, Monoclonal, Humanized | Cost-Benefit Analysis | HumansYear: 2020Local holdings: Available online from MWHC library: 1995 - present, Available in print through MWHC library:1999-2007ISSN:- 0735-1097
Item type | Current library | Collection | Call number | Status | Date due | Barcode |
---|---|---|---|---|---|---|
Journal Article | MedStar Authors Catalog | Article | 32381161 | Available | 32381161 |
Available online from MWHC library: 1995 - present, Available in print through MWHC library:1999-2007
English